IGF-1R activation seems to have an essential role in tumor cell proliferation of different tumor types (De Santi et al., 2016; Svalina et al., 2016; von Wichert et al., 2000), which has provided reason to incorporate anti-IGF-1R drugs in the frame of the disease management. This evidence concerns the gene IGF1R and neoplasm.